Status:
UNKNOWN
Diagnostic Accuracy of Salivary Gamma-synuclein in Oral Malignant and Premalignant Lesions
Lead Sponsor:
Cairo University
Conditions:
Oral Cancer
Oral Lichen Planus
Eligibility:
All Genders
20-80 years
Brief Summary
Synucleins are a family of small, highly conserved proteins found in vertebrates and are specially abundant in neurons particularly in presynaptic terminals (Surguchov et al., 2001). Gamma-synuclein i...
Eligibility Criteria
Inclusion
- Group 1: patients with malignant lesions will be diagnosed through clinical and histopathological examination of tissue biopsy.
- Group 2: patients with oral potentially malignant lesions will be diagnosed clinically and histopathological examination of tissue biopsy.
- Group 3: healthy individuals who will be examined clinically through conventional visual and tactile examination to ensure no oral lesions are present and through thorough medical history
Exclusion
- \-
Key Trial Info
Start Date :
March 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 10 2021
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT04732741
Start Date
March 10 2021
End Date
December 10 2021
Last Update
February 1 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.